** J.P.Morgan upgrades beauty and skincare firm Bath & Body Works BBWI.N to "overweight" from "neutral", citing potential for revenue growth in FY25
** Brokerage sees BBWI's "three-legged stool" of product innovation, marketing and technology supporting growth within its "core" categories of home fragrance, body care, and hand soaps/sanitizers
** J.P.Morgan raises target price to $47 from $41, representing a ~29% upside from last close
** Brokerage says, "We see sales growth and therefore fixed cost leverage as the primary driver to bridge operating margins to management's ~20% long-term target"
** 13 of 19 brokerages rate the stock "buy" or higher, 5 "hold" and 1 "sell" or lower; their median PT is $45
** Up to last close, BBWI stock which fell 10% in 2024, was down 6% YTD in 2025
(Reporting by Kanchana Chakravarty in Bengaluru)
((Kanchana.Chakravarty@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.